vs

Side-by-side financial comparison of CME Group (CME) and INSPERITY, INC. (NSP). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.7B, roughly 1.1× INSPERITY, INC.). On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 3.4%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -3.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Insperity, Inc., previously known as Administaff, Inc., is a professional employer organization (PEO) headquartered in Kingwood, an area of Houston, Texas, USA. Insperity provides human resources and administrative services to small and medium-sized businesses. Since 2004, the company has been title sponsor of a professional golf tournament on the Champions Tour, previously known as the Administaff Small Business Classic.

CME vs NSP — Head-to-Head

Bigger by revenue
CME
CME
1.1× larger
CME
$1.9B
$1.7B
NSP
Growing faster (revenue YoY)
CME
CME
+11.1% gap
CME
14.5%
3.4%
NSP
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-3.8%
NSP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
NSP
NSP
Revenue
$1.9B
$1.7B
Net Profit
$1.2M
Gross Margin
10.3%
Operating Margin
0.1%
-2.8%
Net Margin
0.1%
Revenue YoY
14.5%
3.4%
Net Profit YoY
20.7%
EPS (diluted)
$-0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
NSP
NSP
Q1 26
$1.9B
Q4 25
$1.6B
$1.7B
Q3 25
$1.5B
$1.6B
Q2 25
$1.7B
$1.7B
Q1 25
$1.6B
$1.9B
Q4 24
$1.5B
$1.6B
Q3 24
$1.6B
$1.6B
Q2 24
$1.5B
$1.6B
Net Profit
CME
CME
NSP
NSP
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
$-20.0M
Q2 25
$1.0B
$-5.0M
Q1 25
$956.2M
$51.0M
Q4 24
$874.6M
Q3 24
$912.8M
$3.0M
Q2 24
$883.2M
$18.0M
Gross Margin
CME
CME
NSP
NSP
Q1 26
Q4 25
10.3%
Q3 25
12.0%
Q2 25
13.4%
Q1 25
16.6%
Q4 24
13.5%
Q3 24
14.7%
Q2 24
16.2%
Operating Margin
CME
CME
NSP
NSP
Q1 26
0.1%
Q4 25
61.8%
-2.8%
Q3 25
63.3%
-1.5%
Q2 25
66.7%
-0.4%
Q1 25
67.5%
3.7%
Q4 24
62.1%
-0.9%
Q3 24
64.6%
0.1%
Q2 24
65.3%
1.4%
Net Margin
CME
CME
NSP
NSP
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
-1.2%
Q2 25
60.6%
-0.3%
Q1 25
58.2%
2.7%
Q4 24
57.3%
Q3 24
57.6%
0.2%
Q2 24
57.6%
1.1%
EPS (diluted)
CME
CME
NSP
NSP
Q1 26
Q4 25
$3.24
$-0.87
Q3 25
$2.49
$-0.53
Q2 25
$2.81
$-0.14
Q1 25
$2.62
$1.35
Q4 24
$2.40
$-0.21
Q3 24
$2.50
$0.07
Q2 24
$2.42
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
NSP
NSP
Cash + ST InvestmentsLiquidity on hand
$2.4B
$682.0M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$46.0M
Total Assets
$202.0B
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
NSP
NSP
Q1 26
$2.4B
Q4 25
$4.5B
$682.0M
Q3 25
$2.6B
$521.0M
Q2 25
$2.1B
$511.0M
Q1 25
$1.5B
$684.0M
Q4 24
$3.0B
$1.2B
Q3 24
$2.4B
$596.0M
Q2 24
$1.9B
$850.0M
Total Debt
CME
CME
NSP
NSP
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
NSP
NSP
Q1 26
Q4 25
$28.7B
$46.0M
Q3 25
$28.2B
$87.0M
Q2 25
$27.7B
$112.0M
Q1 25
$27.0B
$119.0M
Q4 24
$26.5B
$97.0M
Q3 24
$28.2B
$125.0M
Q2 24
$27.6B
$142.0M
Total Assets
CME
CME
NSP
NSP
Q1 26
$202.0B
Q4 25
$198.4B
$2.2B
Q3 25
$187.1B
$2.0B
Q2 25
$179.9B
$2.0B
Q1 25
$157.8B
$2.1B
Q4 24
$137.4B
$2.6B
Q3 24
$137.8B
$1.9B
Q2 24
$123.4B
$2.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
NSP
NSP
Operating Cash FlowLast quarter
$255.0M
Free Cash FlowOCF − Capex
$246.0M
FCF MarginFCF / Revenue
14.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-309.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
NSP
NSP
Q1 26
Q4 25
$1.1B
$255.0M
Q3 25
$968.1M
$-11.0M
Q2 25
$1.1B
$-79.0M
Q1 25
$1.1B
$-443.0M
Q4 24
$1.0B
$619.0M
Q3 24
$1.0B
$-150.0M
Q2 24
$776.9M
$20.0M
Free Cash Flow
CME
CME
NSP
NSP
Q1 26
Q4 25
$1.1B
$246.0M
Q3 25
$949.7M
$-20.0M
Q2 25
$1.0B
$-86.0M
Q1 25
$1.1B
$-449.0M
Q4 24
$991.7M
$606.0M
Q3 24
$973.2M
$-164.0M
Q2 24
$758.7M
$14.0M
FCF Margin
CME
CME
NSP
NSP
Q1 26
Q4 25
66.8%
14.7%
Q3 25
61.8%
-1.2%
Q2 25
61.5%
-5.2%
Q1 25
67.1%
-24.1%
Q4 24
65.0%
37.6%
Q3 24
61.4%
-10.5%
Q2 24
49.5%
0.9%
Capex Intensity
CME
CME
NSP
NSP
Q1 26
Q4 25
2.0%
0.5%
Q3 25
1.2%
0.6%
Q2 25
1.1%
0.4%
Q1 25
0.9%
0.3%
Q4 24
1.7%
0.8%
Q3 24
1.9%
0.9%
Q2 24
1.2%
0.4%
Cash Conversion
CME
CME
NSP
NSP
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
-8.69×
Q4 24
1.16×
Q3 24
1.10×
-50.00×
Q2 24
0.88×
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

NSP
NSP

Northeast$455.0M27%
West$339.0M20%
Southwest$317.0M19%
Central$299.0M18%
Southeast$241.0M14%
Other Revenues$17.0M1%

Related Comparisons